Hermetica Superfood Encyclopedia
The Short Answer
Caesalpinia bonduc seeds contain cassane and norcassane diterpenoids—including bonducin and caesalpinins—alongside flavonoids such as quercetin-3-methyl ether, which interact with pro-inflammatory enzymes and angiogenic targets to produce antipyretic, anti-inflammatory, and cytotoxic effects in preclinical models. All evidence derives from in vitro, in silico, and animal studies, with quercetin-3-methyl ether demonstrating the strongest cytotoxic inhibition against HeLa cells in ethyl acetate fractions and rhizome extracts reducing fever in rodent antipyretic assays; no human clinical trials have been conducted.
CategoryHerb
GroupPacific Islands
Evidence LevelPreliminary
Primary KeywordTalisitoto Caesalpinia bonduc benefits
Talisitoto — botanical close-up
Health Benefits
**Antipyretic (Fever Reduction)**
Rhizome extracts of Caesalpinia bonduc have demonstrated fever-reducing activity in rodent models, supporting the Samoan traditional use of seeds and plant parts for febrile illness; the mechanism is attributed to secondary metabolites including diterpenoids that modulate prostaglandin-mediated thermoregulatory pathways.
**Anti-inflammatory Activity**
Ethanolic and aqueous extracts inhibit albumin denaturation, suppress proteinase activity, and reduce erythrocyte hemolysis in vitro, indicating broad suppression of inflammatory cascades; saponins, flavonoids, and phenolic acids including caffeic and ferulic acid are the primary contributors identified.
**Cytotoxic and Potential Anticancer Properties**
Quercetin-3-methyl ether isolated from leaf ethyl acetate fractions exhibited the strongest inhibitory activity against HeLa cervical cancer cells in vitro, while in silico docking showed flavonoids binding tyrosine kinase, VEGF, and MMP targets with energies of -7.7 to -10.3 kcal/mol, outperforming the reference inhibitor batimastat (-6.7 kcal/mol) at MMP; apoptosis appears mediated through Bax upregulation and PARP activation.
**Hypoglycemic Effects**
Leaf extracts rich in flavonoids have shown blood glucose-lowering activity in animal models by enhancing insulin secretion, improving glucose tolerance, and reducing insulin resistance through antioxidant modulation of glucose metabolic pathways; pinitol, a cyclitol present in leaves, is specifically recognized as an insulin-sensitizing compound.
**Antioxidant Protection**
Phenolic acids including gallic, chlorogenic, p-coumaric, and caffeic acid, alongside flavonoids quercetin and kaempferol glycosides, contribute to free radical scavenging activity demonstrated in standard DPPH and ABTS assays in multiple extract screenings.
**Antimalarial Properties**
Traditional use of seeds for malaria across Pacific, African, and Asian populations is supported by in vitro and animal-model evidence, with cassane diterpenoids—particularly bonducin—identified as the primary antimalarial constituents acting against Plasmodium species.
**Hepatoprotective Effects**
Extracts have shown preliminary hepatoprotective activity attributed to antioxidant phytochemicals reducing oxidative liver damage in preclinical settings, though mechanisms remain poorly characterized beyond general antioxidant and anti-inflammatory actions.
Origin & History
Natural habitat
Caesalpinia bonduc is a scrambling, thorny shrub in the family Fabaceae native to pantropical coastal regions, including the Pacific Islands, South and Southeast Asia, Africa, and the Caribbean, where it colonizes beach margins, forest edges, and disturbed tropical habitats. In Samoa and broader Polynesia, the plant grows wild along coastlines and is gathered opportunistically rather than formally cultivated, thriving in sandy, well-drained soils under full sun and high humidity. Its hard, grey-green seeds are distributed by ocean currents, which accounts for its remarkably wide pantropical distribution across Pacific Island nations.
“Caesalpinia bonduc has been integrated into traditional medicine across the Pacific Islands, South Asia, West Africa, and the Caribbean for centuries, with Samoan healers (fofo) specifically employing the seeds under the name Talisitoto to manage febrile conditions in adults and children. In Ayurvedic medicine, the plant—known as Lata-karanja—features in classical formulations for treating worm infestations, intermittent fevers attributed to malaria, hydrocele, and uterine disorders, with seeds roasted or ground into powders and combined with adjuvants such as ginger or black pepper. Across West African ethnomedicine, seeds and leaves are prepared as decoctions for smallpox management, wound healing, and as anthelmintics, while Filipino and Indonesian traditional systems use leaf poultices for inflammation and skin infections. The plant's hard, buoyant seeds—historically called 'nickernuts' or 'grey nickers' by Caribbean and Atlantic coastal communities—were also used ornamentally and in children's games, giving the plant deep cultural embeddedness beyond purely medicinal roles across many Pacific and tropical societies.”Traditional Medicine
Scientific Research
The evidence base for Talisitoto (Caesalpinia bonduc) consists exclusively of preclinical in vitro cytotoxicity studies on cell lines such as HeLa, in silico molecular docking simulations, and animal model experiments including rodent antipyretic and hypoglycemic assays—no human clinical trials have been registered or published as of the available literature. In vitro work identified quercetin-3-methyl ether as the most potent cytotoxic constituent in ethyl acetate leaf fractions against HeLa cells, though specific IC50 values and comparative benchmarks against standard chemotherapeutics are not uniformly reported across studies. Molecular docking analyses provided binding energy data suggesting flavonoid affinity for cancer-relevant targets (TK, VEGF, MMP) superior to some reference inhibitors, but docking results are computational predictions that cannot substitute for experimental pharmacological validation. GC-MS profiling of seed volatile constituents identified hexadecanoic acid and octadecadienoate derivatives without quantified bioactive concentrations, and ADMET in silico modeling suggests favorable pharmacokinetic profiles for lead flavonoids, but the overall evidence base is rated as preliminary and insufficient to support therapeutic claims in humans.
Preparation & Dosage
Traditional preparation
**Traditional Seed Decoction (Samoan)**
Seeds are cleaned, cracked, and boiled in water to prepare a crude decoction used orally for fever; no standardized volume or seed-to-water ratio has been documented in the published literature.
**Ethanolic Leaf Extract (Research Use)**
100–500 mg/mL for bioactivity screening; these are not formulated for human consumption
Laboratory studies employ 70–95% ethanol maceration of dried leaves at concentrations of .
**Aqueous Rhizome Extract (Antipyretic)**
Rodent antipyretic studies use aqueous rhizome preparations administered at experimental doses (mg/kg body weight) not translatable to safe human dosing without further study.
**No Standardized Commercial Form**
No standardized supplement, extract percentage, or pharmaceutical-grade preparation of Caesalpinia bonduc is commercially available or regulatory-approved for human use in any jurisdiction.
**Dosage Guidance**
Effective and safe human doses are entirely undefined; extrapolation from traditional use or animal studies is not recommended without clinical oversight due to the absence of toxicological dose-finding studies in humans.
Nutritional Profile
Seeds contain meaningful concentrations of fatty acids—including palmitic (hexadecanoic) acid, stearic acid, lignoceric acid, oleic acid, and linolenic acid—alongside starch as a primary carbohydrate reserve, sucrose, and seed storage proteins, though precise macronutrient percentages have not been published in peer-reviewed nutritional analyses. Phytosterols including beta-sitosterol are present in seed fractions and contribute to membrane-active and cholesterol-modulating properties. Leaves supply phenolic acids (gallic, chlorogenic, caffeic, p-coumaric, ferulic) and flavonoid glycosides (kaempferol-3-O-β-D-xylopyranoside, kaempferol-3-O-α-L-rhamnopyranosyl-(1→2)-β-D-xylopyranoside, quercetin-3-methyl ether, luteolin, brazillin) alongside the cyclitol pinitol, a known insulin sensitizer. Bioavailability of the major bioactives is uncharacterized in humans; in silico ADMET modeling of flavonoid leads predicts acceptable oral absorption and metabolic stability, but experimental pharmacokinetic data from animal or human studies are absent.
How It Works
Mechanism of Action
Cassane diterpenoids such as bonducin and caesalpinins in the seeds exert antipyretic and antimalarial effects by interfering with arachidonic acid-derived prostaglandin synthesis and disrupting Plasmodium metabolic processes, though precise receptor-level targets remain uncharacterized. Flavonoids—notably quercetin-3-methyl ether, luteolin, and kaempferol glycosides from leaves—inhibit angiogenesis and tumor proliferation by binding tyrosine kinase receptors and VEGF signaling nodes (molecular docking energies -7.7 to -10.3 kcal/mol), while simultaneously upregulating the pro-apoptotic protein Bax and activating poly(ADP-ribose) polymerase (PARP) cleavage to induce programmed cell death. Anti-inflammatory activity operates through inhibition of protein denaturation and suppression of proteinase enzymes that propagate the inflammatory cascade, with phenolic acids such as caffeic and ferulic acid contributing additional cyclooxygenase pathway inhibition. Hypoglycemic effects are mediated by flavonoid-driven enhancement of pancreatic insulin secretion combined with pinitol's insulin-mimetic action on glucose transporter activity and antioxidant reduction of oxidative stress that underlies insulin resistance.
Clinical Evidence
No clinical trials in human populations have been conducted on Talisitoto (Caesalpinia bonduc) for any indication, including its primary Samoan traditional use for fever management. The existing evidence hierarchy consists of cell-line studies, rodent models, and computational analyses, none of which provide effect sizes, confidence intervals, or safety data applicable to human dosing. Preclinical antipyretic data from rhizome studies in rodents and hypoglycemic data from leaf extract animal models suggest biological plausibility for traditional uses, but translation to clinical efficacy cannot be assumed without randomized controlled trials. Confidence in any therapeutic recommendation is very low, and all uses remain categorized as traditional/ethnopharmacological rather than evidence-based clinical practice.
Safety & Interactions
Systematic toxicological evaluation of Talisitoto (Caesalpinia bonduc) in humans has not been performed, and no established maximum safe doses, NOAEL values, or formal toxicity classifications exist for any plant part or extract. In vitro data show that seed extracts do not inhibit the probiotic bacterium Lactobacillus rhamnosus, suggesting limited disruption of beneficial gut flora at tested concentrations, and in silico ADMET profiling predicts acceptable toxicity parameters for key flavonoids, but these findings do not substitute for in vivo or clinical toxicology. Potential drug interactions are unstudied; given the plant's demonstrated hypoglycemic activity in animal models, concurrent use with antidiabetic medications (insulin, metformin, sulfonylureas) carries a theoretical risk of additive hypoglycemia, and anti-inflammatory constituents could theoretically interact with anticoagulants or NSAIDs. Use during pregnancy and lactation is contraindicated based on traditional reports of antifertility activity attributed to seed constituents, and caution is warranted in pediatric populations, immunocompromised individuals, and patients with hepatic impairment until formal safety data are available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Caesalpinia bonducLata-karanjaFever nutGrey nickerBonduc nutNata de bonducKakachinti
Frequently Asked Questions
What is Talisitoto used for in Samoan traditional medicine?
In Samoan traditional medicine, Talisitoto refers to Caesalpinia bonduc, a thorny coastal shrub whose seeds are primarily prepared as a decoction and administered orally to reduce fever. The antipyretic use aligns with broader Pacific and South Asian traditional applications of the plant for febrile conditions, including malaria-associated fever, and is supported by rodent antipyretic studies using rhizome extracts, though no human clinical trials confirm efficacy or safe dosing.
What are the main bioactive compounds in Caesalpinia bonduc seeds?
The seeds of Caesalpinia bonduc are richest in cassane diterpenoids—including caesalpinins, caesalmins, and bonducin—alongside norcassane diterpenoids, phytosterols (beta-sitosterol), fatty acids (palmitic, oleic, linolenic), starch, sucrose, saponins, and seed storage proteins. Bonducin is considered a principal bioactive compound responsible for antimalarial and antipyretic properties, while GC-MS analysis has also identified hexadecanoic acid and octadecadienoate esters, though precise quantitative concentrations for individual compounds have not been standardized in the published literature.
Is Caesalpinia bonduc safe to use, and are there any drug interactions?
Formal human safety studies for Caesalpinia bonduc have not been conducted, so no established safe dose or toxicity threshold exists for any plant part. Seed extracts did not harm the probiotic bacterium Lactobacillus rhamnosus in vitro, and in silico ADMET modeling predicts acceptable safety profiles for key flavonoids; however, the plant's hypoglycemic activity in animal models creates a theoretical risk of additive hypoglycemia when combined with antidiabetic medications such as metformin or insulin, and traditional reports of antifertility effects mean use during pregnancy should be avoided.
Has Caesalpinia bonduc been studied in clinical trials for cancer or diabetes?
No clinical trials in humans have been conducted for Caesalpinia bonduc for any indication, including cancer or diabetes. Evidence for anticancer properties is limited to in vitro cytotoxicity studies showing that quercetin-3-methyl ether from leaf extracts inhibits HeLa cervical cancer cells, and in silico docking data indicating flavonoids bind cancer targets (VEGF, tyrosine kinase, MMP) with favorable energies; hypoglycemic evidence derives from animal models using leaf extracts, and neither line of research supports therapeutic claims in humans without further clinical investigation.
What other traditional medicinal uses does Talisitoto (Caesalpinia bonduc) have beyond fever?
Beyond fever management, Caesalpinia bonduc is used across multiple traditional medicine systems for a wide range of conditions: seeds are employed for antimalarial and antifertility purposes, leaves are used as antidiabetic and anti-inflammatory remedies, rhizomes are prepared for antipyretic effects, and various plant parts address wounds, tumors, hydrocele, hernia, smallpox, toothache, and intestinal worm infestations. Preclinical studies partially validate anti-inflammatory, hypoglycemic, and antimicrobial activities attributed to flavonoids, phenolic acids, and diterpenoids, though none of these applications have progressed to human clinical trials.
What is the most effective form of Caesalpinia bonduc for fever reduction—seeds, extracts, or rhizome preparations?
Traditionally, Samoan medicine uses the seeds most commonly, though rhizome extracts have shown the strongest antipyretic activity in laboratory studies due to higher concentrations of diterpenoids. Standardized seed or rhizome extracts may offer more consistent dosing than whole plant preparations, but clinical evidence comparing bioavailability across forms remains limited. The active compounds in seeds and rhizomes are believed to modulate prostaglandin-mediated fever pathways, though absorption rates vary depending on preparation method and individual digestive factors.
Is Talisitoto (Caesalpinia bonduc) safe for use in children with fever?
While Caesalpinia bonduc has been used traditionally in Samoan pediatric practice for fever management, specific safety data for children is sparse and dosing guidelines are not well-established in clinical literature. The presence of potentially toxic alkaloids in some plant parts necessitates caution, and pediatric use should only occur under qualified healthcare supervision. Parents should consult with practitioners familiar with this herb before giving it to children, as age-appropriate dosing and preparation standards have not been formally defined.
How does the anti-inflammatory potency of Caesalpinia bonduc compare to commonly used herbal anti-inflammatories like turmeric or ginger?
Caesalpinia bonduc contains diterpenoids and secondary metabolites with documented anti-inflammatory activity in laboratory models, but direct clinical comparison studies against turmeric (curcumin) or ginger are absent from the peer-reviewed literature. Turmeric and ginger have substantially more human clinical data supporting anti-inflammatory efficacy, while Caesalpinia bonduc research remains primarily in preclinical and traditional use stages. The relative potency and practical effectiveness of Talisitoto for inflammatory conditions cannot be definitively ranked without head-to-head human trials.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w talisitoto-caesalpinia-bonduc curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
